Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Identification of Genetic Subtypes in Follicular Lymphoma

Blood (2022) 140 (Supplement 1): 6371–6373.

https://doi.org/10.1182/blood-2022-164610

Published: 2022

Journal Articles

Gene Expression Analysis Reveals Downregulation of Complement Receptor 1 in Cold Agglutinin Disease

Agnieszka Malecka, Ingunn Ostlie, Gunhild Trøen, Jędrzej M. Małecki, Jan Delabie, Anne Tierens, Sigbjørn Berentsen, Geir E Tjønnfjord

Blood (2022) 140 (Supplement 1): 6419–6420.

https://doi.org/10.1182/blood-2022-156489

Published: 2022

Journal Articles

Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

Blood (2022) 140 (Supplement 1): 3532–3533.

https://doi.org/10.1182/blood-2022-156571

Published: 2022

Journal Articles

Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial

Blood (2022) 140 (Supplement 1): 1479–1480.

https://doi.org/10.1182/blood-2022-158981

Published: 2022

Journal Articles

Protein Profiling Identify Distinct Tumor-Tissue Protein Expression Pattern Specific for Relapsing Diffuse Large B-Cell Lymphoma

Maja Ludvigsen, Diani Wilken, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Lars Pedersen, Jan Delabie, Francesco d'Amore, Harald Holte, Sirpa Leppa, Judit Jørgensen, Bent Honoré

Blood (2021) 138 (Supplement 1): 4499.

https://doi.org/10.1182/blood-2021-145690

Published: 2021

Journal Articles

The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project

Blood (2021) 138 (Supplement 1): 1326.

https://doi.org/10.1182/blood-2021-153441

Published: 2021

Journal Articles

The Mutational Landscape of Cold Agglutinin Disease

Agnieszka Malecka, PhD, Gunhild Trøen, PhD, Jan Delabie, MDPhD, Ingunn Ostlie, Anne Tierens, MD PhD, Ulla Randen, MD PhD, Sigbjørn Berentsen, Geir Erland Tjønnfjord, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-133760

Published: 2020

Journal Articles

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Agnieszka Malecka, Jan Delabie, MD PhD, Ingunn Ostlie, Anne Tierens, MD PhD, Ulla Randen, MD PhD, Sigbjorn Berentsen, MD PhD, Geir Erland Tjønnfjord, MD PhD, Gunhild Trøen

Blood (2019) 134 (Supplement_1): 1488.

https://doi.org/10.1182/blood-2019-121750

Published: 2019

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Anca Prica, MD, Ryan D. Morin, PhD, Vishal Kukreti, MD, Robert Kridel, MDMPH,PhD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, Miguel Alcaide, Rashmi S. Goswami, MD PhD, Jan Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, MBChB, PhD, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 2027.

https://doi.org/10.1182/blood-2019-131818

Published: 2019

Journal Articles

Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma

Xiang Li, Rachel Kositsky, Anupama Reddy, PhD, Cassandra Love, Kikkeri Naresh, Jean L. Koff, MD, Ilja Nystrand, Sirpa Leppä, MD PhD, Annika Pasanen, MD PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Johannes Dunkel, Panu Kovanen, MD PhD, Qiu Qin, Govind Bhagat, MD, Rebecca J Leeman-Neill, MDPhD, Rashmi S. Goswami, MD PhD, Sarah Wildeman, Jan Delabie, MDPhD, Richard Burack, MD PhD, Andrew G Evans, MD PhD, Catalina Amador, MD, Ji Yuan, Hina Naushad Qureishi, Shaoying Li, MD, Jie Xu, C. Cameron Yin, MD PhD, Anne Ortved Gang, Peter H. Norgaard, MDPhD, Mette Ø Pedersen, MD, Jason Yongsheng Chan, MBBS, MRCP, Daryl Ming Zhe Cheah, Shin Yeu Ong, MD FRCPath, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Lianne Lee, Felik Paulua, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Magdalena Czader, MD PhD, Lin Wang, PhD, Amber Landis, Michael C. Churnetski, David L. Jaye, MD, Christopher R. Flowers, MD MS, Chad M. McCall, MD PhD, Jadee Neff, MD PhD, Matthew S. McKinney, MD, Yuri Fedoriw, Eric Powers, Nathan D Montgomery, MD, Agata M. Bogusz, MDPhD, Andrea Stafford Hintz, HSLT, Alexandra E. Kovach, MD, Nishitha Reddy, MD, Mary Ann Thompson Arildsen, MD PhD, Emily F Mason, MD PhD, Ridas Juskevicius, MD, William Choi, MBBS,MRCP, Rex Au-Yeung, Eric Tse, MBBS, PhD FRCP, FRCPath, Vincent Sarno, Amy Chadburn, MD, Rafael Lopez, MD, Jennifer R Chapman, MD, Amir Behdad, MD, Neta Goldschmidt, MD, John Goodlad, MD, Cathy Burton, Raju Pillai, MD, Abner Louissaint, Jr., MD PhD, Dina Sameh Soliman, MD MB, MMSc, Razvan Panea, Tushar Dave, Barbara Xiong, Eileen Smith, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 19.

https://doi.org/10.1182/blood-2019-130255

Published: 2019

Journal Articles

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

Blood (2019) 133 (9): 940–951.

https://doi.org/10.1182/blood-2018-07-862151

Published: 2019

Includes: Supplemental data

Journal Articles

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens

Blood (2018) 132 (22): 2401–2405.

https://doi.org/10.1182/blood-2018-05-851154

Published: 2018

Includes: Supplemental data

Journal Articles

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Blood (2018) 132 (4): 413–422.

https://doi.org/10.1182/blood-2018-03-838136

Published: 2018

Includes: Supplemental data

Journal Articles

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Blood (2017) 130 (16): 1819–1831.

https://doi.org/10.1182/blood-2017-02-767335

Published: 2017

Includes: Supplemental data

Journal Articles

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

June H. Myklebust, Joshua Brody, Holbrook E. Kohrt, Arne Kolstad, Debra K. Czerwinski, Sébastien Wälchli, Michael R. Green, Gunhild Trøen, Knut Liestøl, Klaus Beiske, Roch Houot, Jan Delabie, Ash A. Alizadeh, Jonathan M. Irish, Ronald Levy

Blood (2017) 129 (6): 759–770.

https://doi.org/10.1182/blood-2016-05-718494

Published: 2017

Includes: Supplemental data

Journal Articles

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Blood (2015) 125 (17): 2669–2677.

https://doi.org/10.1182/blood-2014-06-584193

Published: 2015

Includes: Supplemental data

Journal Articles

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Blood (2015) 125 (7): 1137–1145.

https://doi.org/10.1182/blood-2014-04-566778

Published: 2015

Includes: Supplemental data

Journal Articles

Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma

Arne Kolstad, Shraddha Kumari, Mateusz Walczak, Ulf Madsbu, Trond Hagtvedt, Trond Velde Bogsrud, Gunnar Kvalheim, Harald Holte, Ellen Aurlien, Jan Delabie, Anne Tierens, Johanna Olweus

Blood (2015) 125 (1): 82–89.

https://doi.org/10.1182/blood-2014-07-592162

Published: 2015

Includes: Supplemental data

Journal Articles

Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status

Samantha L. Kendrick, PhD, Katalin Tus, MD, David W. Scott, MBChB, PhD, George Wright, PhD, Elaine S. Jaffe, MD, Andreas Rosenwald, MD, Elías Campo, MD PhD, Wing Chung Chan, MD, Joseph M. Connors, MD, Rita M. Braziel, MD, German Ott, MD, Jan Delabie, MD PhD, James R. Cook, MD PhD, Dennis D. Weisenburger, MD, Timothy C. Greiner, MS, MD, Kai Fu, MD PhD, Louis M. Staudt, MD PhD, Randy D. Gascoyne, MD, Lisa M. Rimsza, MD

Blood (2014) 124 (21): 1667.

https://doi.org/10.1182/blood.V124.21.1667.1667

Published: 2014

Journal Articles

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma in the Bone Marrow: Paratrabecular Involvement As an Important Distinguishing Feature

Assia Bassarova, MD PhD, Gunhild Trøen, PhD, Signe Spetalen, MD PhD, Francesca Micci, PhD, Anne Tierens, MD PhD, Jan Delabie, MD PhD

Blood (2014) 124 (21): 5399.

https://doi.org/10.1182/blood.V124.21.5399.5399

Published: 2014

NARROW

Identification of Genetic Subtypes in Follicular Lymphoma

Gene Expression Analysis Reveals Downregulation of Complement Receptor 1 in Cold Agglutinin Disease

Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial

Protein Profiling Identify Distinct Tumor-Tissue Protein Expression Pattern Specific for Relapsing Diffuse Large B-Cell Lymphoma

The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project

The Mutational Landscape of Cold Agglutinin Disease

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma

Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma in the Bone Marrow: Paratrabecular Involvement As an Important Distinguishing Feature

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only